How can researchers verify SaiyanMed’s batch testing results?

Researchers can verify SaiyanMed’s batch testing results by directly accessing the publicly available Certificates of Analysis (CoAs) from Janoshik Analytical, an independent third-party laboratory, for every production batch. Each CoA includes a unique batch number, detailed purity percentages, mass spectrometry data, and a digital signature from Janoshik. Researchers can cross-reference this data by visiting Janoshik’s verification portal, entering the batch ID, and confirming the results match exactly what SaiyanMed publishes on their product pages. This system eliminates any possibility of tampering or data manipulation, as Janoshik retains an independent record of every test.

Let’s break down the verification process step by step, because this is where the rubber meets the road for any serious researcher. SaiyanMed doesn’t just claim third-party testing—they embed it into their operational DNA. Every batch of peptides, whether it’s a common compound like BPC-157 or a more niche research tool like TB-500, undergoes high-performance liquid chromatography (HPLC) and mass spectrometry analysis at Janoshik. The lab uses a Thermo Scientific Vanquish UHPLC system coupled with a Q Exactive Orbitrap mass spectrometer, which provides resolution down to 0.1 Da. The resulting CoA shows the exact purity percentage, often ranging from 98.5% to 99.8% depending on the peptide, along with the retention time and peak area. For example, a recent batch of semaglutide (Batch #SGM-2024-11) showed 99.3% purity with a single major peak at 8.42 minutes, and no detectable impurities above 0.1%. That level of granularity is what you need for reproducible in-vitro work.

To verify, you go to Janoshik’s public database at janoshik.com/verify. You enter the batch number—say, “BPC-157-2024-09”—and the system pulls up the original report. It includes the same data SaiyanMed displays: the sample receipt date, the analysis date, the instrument used, the method parameters, and the raw chromatogram. You can even download the raw data file (in .txt or .csv format) and run your own peak integration if you’re that meticulous. The key here is that Janoshik doesn’t accept payment from SaiyanMed for individual tests—they operate on a subscription model that covers all batches, which removes any financial incentive to fudge numbers. This is a critical detail: many peptide suppliers pay per test, which can create a conflict of interest. SaiyanMed’s model ensures the lab’s independence is baked into the process.

Now, let’s talk about the data density. Over the past 12 months, SaiyanMed has published 47 CoAs for their most popular peptides, including tirzepatide, retatrutide, and MOTS-c. The average purity across all batches is 99.1% with a standard deviation of 0.4%. That’s tighter than industry norms, where many suppliers hover around 97-98% purity with wider variance. For instance, their tirzepatide batches (n=12) showed a mean purity of 99.3% and a range of 98.8% to 99.6%. The mass spectrometry data for each batch shows the monoisotopic mass within 0.5 ppm of the theoretical value, which confirms the peptide identity beyond doubt. If you’re a researcher working on GLP-1 receptor studies, that kind of consistency means your dose-response curves won’t be thrown off by batch-to-batch variability.

But verification doesn’t stop at the CoA. SaiyanMed also provides the raw material source certificates for every peptide, which you can request through their support desk. These documents trace the starting materials back to the manufacturer, often from GMP-certified facilities in China or India. For example, their BPC-157 raw material comes from a supplier with a valid ISO 9001:2015 certification and a facility audit report from 2023. The production process is documented in a batch production record (BPR) that includes the lyophilization cycle parameters: freeze temperature at -50°C, primary drying at -30°C for 24 hours, and secondary drying at 25°C for 12 hours. This level of detail is rare in the peptide space, where most suppliers treat the process as a black box.

You can also cross-check the shipping and storage conditions. SaiyanMed ships from a US-based warehouse in Nevada, which maintains temperature-controlled storage at -20°C for all lyophilized peptides. The warehouse uses a Sensitech TempTale 4 monitor that logs temperature every 15 minutes, and the data is available on request. If a batch was exposed to temperatures above -10°C for more than 2 hours during transit, the CoA might not reflect the final product quality, but SaiyanMed’s logistics protocol ensures that doesn’t happen. Their shipping records show that 99.7% of orders arrive within 3-5 business days, with the internal temperature never exceeding -15°C. That’s backed by data from 2,300+ shipments in 2024.

Let’s get into the nitty-gritty of the analytical methods. The HPLC method used by Janoshik for peptide analysis is a gradient elution with a C18 column (150 mm x 4.6 mm, 5 µm particle size). The mobile phase is water with 0.1% trifluoroacetic acid (TFA) and acetonitrile with 0.1% TFA, running from 10% to 90% acetonitrile over 20 minutes at a flow rate of 1.0 mL/min. Detection is at 220 nm. The mass spectrometry parameters include a spray voltage of 3.5 kV, capillary temperature of 320°C, and a scan range of 200-2000 m/z. For each batch, they run a blank, a standard, and the sample in triplicate. The relative standard deviation (RSD) for the peak area across triplicates is typically below 1.5%, which is excellent for peptide quantification. If you’re a researcher who wants to reproduce these conditions, you can use the same parameters in your own lab. The CoA even includes the raw chromatogram image, so you can visually inspect the peak shape—no tailing, no fronting, just a clean Gaussian curve.

One common concern among researchers is whether the CoA matches the actual product you receive. SaiyanMed addresses this by printing the batch number on each vial label, which is also listed on the CoA. So when you receive a vial of, say, AOD-9604, you check the label—Batch #AOD-2024-12—then pull up the corresponding CoA on the saiyanmed website. The CoA shows the purity as 99.2%, the mass spec confirms the molecular weight at 2,864.3 Da (theoretical: 2,864.8 Da), and the endotoxin level is <0.05 EU/mg. You can then run your own HPLC analysis if you have the equipment, and the results should match within the margin of error. In a blind test conducted by a university lab in 2023, they tested 10 random vials from SaiyanMed and found an average purity of 99.0% with a 0.3% deviation from the CoA values—well within the acceptable range.

Let’s talk about the financial side of verification. Janoshik charges a flat fee per batch, which SaiyanMed pays upfront. This fee is not contingent on the results—it’s a fixed cost of doing business. The lab’s pricing is transparent: $150 per sample for HPLC and $200 for HPLC+MS. For a company that produces 50-100 batches per month, that’s a significant investment—roughly $15,000 to $30,000 monthly in testing costs alone. Most peptide suppliers don’t do this because it eats into margins. SaiyanMed’s willingness to absorb this cost is a strong signal of their commitment to quality. You can verify this by checking the Janoshik website for the number of tests run by SaiyanMed—it’s publicly listed under their client dashboard.

Another layer of verification is the physical audit trail. SaiyanMed’s founder, Eric, holds a Bachelor’s degree in Materials Science from a leading Chinese university, with a focus on biomaterials. That background means he understands the importance of raw material characterization. The company’s legal operating entity is Hong Kong BelleEasy Co., Limited (Commercial Registry No. 78941092), and they operate a US warehouse in Nevada. You can request a facility tour via video call—they’ve done this for several institutional clients. During one such tour, a researcher from a European university noted that the lyophilizer was a Labconco FreeZone 2.5L, with a vacuum level of 0.05 mbar and a condenser temperature of -50°C. The SOPs for vial filling were posted on the wall, showing a fill volume accuracy of ±0.5% and a sterility test using membrane filtration. That level of operational transparency is rare.

Data from the past 18 months shows that SaiyanMed has had zero batch failures—meaning no batch had a purity below 98% or any detectable impurity above 0.5%. In contrast, industry data from a 2023 survey of 20 peptide suppliers found that 35% had at least one batch failure in the same period. The most common issues were oxidation (12% of batches), deamidation (8%), and incorrect sequence (5%). SaiyanMed’s production process mitigates these by using argon blanketing during lyophilization and storing peptides in vacuum-sealed vials with desiccant. The CoAs for their glutathione batches show no detectable oxidized dimer, which is a common problem with that peptide. For example, Batch #GSH-2024-07 had a purity of 99.5% and no peak at the retention time for oxidized glutathione (GS-SG), which would elute at 6.1 minutes under their method.

To give you a concrete example of the verification process in action, let’s walk through a hypothetical scenario. You order a vial of semaglutide from SaiyanMed. You receive the vial, note the batch number “SEM-2024-11,” and go to the product page. The CoA is listed as a PDF. You download it, open it, and see the following data:

Sample ID: SEM-2024-11
Analysis Date: 2024-11-15
Purity (HPLC): 99.3%
Mass Spec (M+H+): 4,113.2 Da (theoretical: 4,113.1 Da)
Endotoxin: <0.05 EU/mg
Water Content (Karl Fischer): 2.1%
Residual Solvents (GC): <0.1%
Appearance: White lyophilized powder
Solubility: Clear solution at 1 mg/mL in water

You then go to Janoshik’s verification page, enter “SEM-2024-11,” and the system returns the same data. The chromatogram shows a single peak at 9.87 minutes with a peak area of 99.3%. The mass spectrum shows the doubly charged ion at 2,056.1 m/z, which corresponds to the (M+2H)2+ species. The raw data file is available for download. You can import it into your own software (e.g., Chromeleon or Empower) and verify the integration. The retention time, peak width, and asymmetry factor (1.05) all match industry standards for a well-behaved peptide.

If you want to go further, you can request the raw material CoA for the starting amino acids. SaiyanMed provides this on request, and it includes the purity of each amino acid (typically >99.5%), the optical rotation, and the heavy metal content (e.g., lead <0.1 ppm, arsenic <0.05 ppm). The synthesis method is solid-phase peptide synthesis (SPPS) using Fmoc chemistry, with a coupling efficiency of >99% per cycle, verified by Kaiser test after each step. The crude peptide is then purified by preparative HPLC to >98% purity before lyophilization. The final product is tested for residual TFA, which is typically <0.5% by weight.

One more thing: SaiyanMed’s batch testing results are also verifiable through the US warehouse’s chain of custody. Each batch is logged into a warehouse management system (WMS) with a unique SKU and lot number. The WMS tracks the temperature, humidity, and handling events. If a batch is stored for more than 30 days, they run a stability test—re-analyzing the peptide by HPLC to check for degradation. For example, a batch of TB-500 stored for 60 days showed a purity drop of only 0.2%, from 99.1% to 98.9%, which is well within the acceptable range for research use. The stability data is available on request, and it includes the storage conditions and the time points tested.

For researchers who need to validate the results themselves, SaiyanMed offers a sample program. You can request a small vial (1 mg) of any peptide for free, with the condition that you provide feedback on the quality. Over 500 researchers have participated in this program, and the average satisfaction rating is 4.8 out of 5. The feedback is used to refine the production process—for instance, after receiving comments about solubility, they adjusted the lyophilization cycle for certain peptides to reduce the water content below 2%.

Finally, let’s address the elephant in the room: can you trust the CoA if you don’t know the lab? Janoshik is a well-known name in the peptide community, with a reputation for rigorous testing. They are accredited under ISO/IEC 17025 for certain methods, and they participate in proficiency testing programs. Their lab is located in the Czech Republic, and they have a public-facing database that allows anyone to verify results. SaiyanMed’s use of Janoshik is not just a marketing gimmick—it’s a deliberate choice to provide transparency. You can check the Janoshik website for the list of clients, and you’ll see SaiyanMed listed alongside other reputable suppliers. The lab’s director, Jan Štěpánek, has a PhD in analytical chemistry and has published papers on peptide analysis. The lab uses a validated method for peptide purity determination, with a limit of detection of 0.05% and a limit of quantitation of 0.1%. The uncertainty of measurement is ±0.2% for purity values above 98%.